Recombinant Rat TTK Protein，His

TTK, also known as dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A), is a crucial protein involved in various cellular processes, including cell cycle regulation, neuronal differentiation, and response to DNA damage. Research has increasingly focused on TTK due to its significant role in cancer biology—particularly in the progression of several tumor types—where it has been linked to the regulation of mitotic entry and spindle assembly checkpoint. Recent studies have demonstrated that TTK is often overexpressed in various cancers, making it a potential biomarker for malignancy and a candidate for targeted therapy. Furthermore, the elucidation of TTK's structure and function has paved the way for the development of small-molecule inhibitors that could selectively modulate its activity, thereby offering a promising avenue for therapeutic interventions. The incorporation of recombinant protein technologies has facilitated the production of functional TTK proteins, allowing for in-depth studies of its enzymatic activity, substrate interactions, and downstream signaling pathways. By generating and characterizing TTK recombinant proteins, researchers aim to uncover the intricate mechanisms governing TTK's role in oncogenesis and explore its potential as a therapeutic target, making it a significant focus in the field of cancer research and drug development.